Eniware portable sterilizer
This project also has a Changeshop where you can read more about its latest progress.
Go to Changeshop: Eniware: Portable Power-Free Medical Equipment .
Infection prevention and room-temperature, power-free gas sterilization for medical instruments in under-resourced health care settings.
A propos de vous
A propos de vous
A propos de votre organisation
Nom
Eniware
Site Web
Pays
États Unis, DC, Washington
Pays dans lesquels ce projet crée un impact social
Inde
Votre organisation est-elle une
Entreprise
Depuis combien de temps votre organisation opère-t-elle ?
Moins d'un année
Votre organisation a-t-elle reçu des récompenses ou des prix ? Si oui, indiquez-nous lesquels.
We're still too new, but "watch this space!".
Références - Veuillez fournir deux références, accompagnées chacune d'une explication de deux lignes, d'une adresse e-mail et d'un numéro de téléphone
Dr. Daniel J. Carucci MD, MSc, PhD:
Dr. Carucci, is the President of Global Health Consulting, Inc. providing consulting services to for-profit and non-profit organizations, international NGOs, multilateral and service organizations who are working toward improving the impact of global health investments. As Vice President for Global Health at the United Nations Foundation, Dr. Carucci supported programs and fostered diverse partnerships to address the United Nations Millennium Development Goals, and as Director of the Grand Challenges in Global Health Initiative at the Foundation for the National Institutes of Health, he oversaw a $200 million investment portfolio of research programs supported by the Bill & Melinda Gates Foundation in cutting edge technologies directed at solving technical barriers to improved global health.
dan@globalhealthconsulting.com
Cell +1 (202) 607-7374
Dr. Linda Wright, MD, Deputy Director for Research for Mothers and Children; Director, Global Network for Women's and Children's Health Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Linda has been Deputy Director of the Center for Research for Mothers & Children (CRMC) since 2003, and between 1989 and 2003, she served as the Program Director of the Neonatal Research Network (NRN), a group of 16 academic medical centers that redefined neonatology as an evidence-based specialty. Dr. Wright provides a unique breadth and depth of expertise in the domestic and developing worlds and has strong ties to other NIH Institutes, funding agencies, non-governmental organizations, and industry.
Phone: 301-402-0830
E-mail: WrightL@mail.nih.gov
Innovation
Sélectionnez la phase qui s'applique le mieux à votre solution
Idée (vous êtes sur le point de lancer le projet)
Depuis combien de temps le projet existe-t-il ?
En place depuis moins d'1 an
Le besoin : quel problème tentez-vous de résoudre ?
Infection and disease transmission in clinics and hospitals afflict millions in the developing world. Sterile medical equipment can mean the difference between life and death. Healthcare associated infection rates in developing countries range from 15% to 40% or more. With the expansion of basic surgery,the problem grows as access to healthcare grows. Potentially lifesaving procedures tragically cripple or kill millions of men,women and children due to lack of affordable,effective sterilization of medical equipment. Safe,effective surgical interventions lower maternal/child mortality and morbidity. Individual health gains benefit the health of society;1/3 of injury-related deaths in the developing world occur in the most economically productive segment of the population - working adults.
La solution: quelle solution proposez-vous ? Soyez précis !
Eniware has licensed a proven, effective NO2 gas sterilization technology from Noxilizer, Inc. NO2 sterilization works at room temperature without electricity. It can sterilize temperature and vacuum sensitive items such as pre-filled syringes and complex or delicate diagnostic devices as well as basic medical supplies in a short period of time. A portable, small-scale sterilization chamber consisting of a plastic bag or box and a simple way to release a small capsule of NO2 would enable healthcare workers to safely sterilize vital supplies anywhere at any time. This approach is scalable, both in terms of unit size and production. The simplicity of the concept provides for minimal training requirements, widespread use, expanded access to safe and effective sterilization, and cost-efficient function at the point of care. The Eniware solution is designed for low- and no-resource settings including disaster areas, conflict zones and hospitals and clinics in the developing world.
Le système : décrivez un exemple spécifique montrant de quelle façon votre initiative fonctionne ; indiquez vos principales activités.
The sterilization challenge is best understood as an ever-expanding effort to provide low-cost infection prevention and safe, high quality healthcare in any setting. Affordable and effective sterilization of medical instruments and devices addresses three interrelated challenges in global health:
1) Healthcare associated infections (HCAI)
2) Expanding basic surgical care
3) Preventing disease transmission: HIV/AIDS, hepatitis, and other diseases
However, resource-limited settings with poor access to reliable electricity and/or clean water inhibit community health workers from effectively sterilizing medical instruments. Eniware's proven technology and cost-effective sterilization will close that gap. For example, WHO estimates that 50 - 100,000 women annually develop obstetrical fistulas, and more than 2M women worldwide live with this devastating condition caused by tissue death during obstructed labor. Low-cost, reliable Eniware sterilization would enable trained birth attendants and community health workers to safely prevent fistula through caesarian section, as well as repair existing fistulas, without fear of contracting life-threatening infection. The ability to efficiently and effectively sterilize medical instruments and thereby expand access to safe, basic surgery is key to restoring these hundreds of thousands of injured women to health and productivity in their families and communities.
Le marché : qui sont vos collègues et vos concurrents ? Identifiez les autres personnes qui travaillent à répondre au même besoin et indiquez ce qui vous différencie d'elles. Comment ces concurrents pourraient-ils influencer votre réussite ou votre croissance ?
In resource-limited and remote environments NO2 sterilization provides the ability to truly sterilize instruments and equipment independent of electrical power or other fuel sources. The system is compatible with a wider array of medical equipment than traditional hi-temp, steam autoclaves. The characteristics of the NO2 gas also provide considerable benefits compared with other gas steriliants like H2O2 and EO: NO2 can penetrate packaging and complex devices,it does not leave residue,it is not explosive and it sterilizes completely even at low concentrations. These traits will allow for an affordable,effective and adaptable sterilization system that requires very little training and can be deployed anywhere from rural and community clinics to field hospitals and disaster relief teams.
This Entry is about (Issues)
Impact social
Création de l'organisation : nous voulons tout savoir sur votre déclic. Expliquez-nous où et quand les fondateurs se sont rendu compte que cette solution possédait un véritable potentiel pour changer le monde.
Eniware's founder,Dr. James Bernstein,instantly recognized the potential for Noxilizer's patented ground-breaking gas sterilant technology to become a game-changer in under-resourced health care settings. When he learned that Noxilizer's business plan focused exclusively on sales to North American/European medical manufacturers and hospitals, Dr. Bernstein licensed the proven patented process for healthcare settings in Africa, Asia and the Middle East, and for military and humanitarian uses worldwide. Originally developed by Noxilizer to sterilize heat- and water-sensitive high tech medical devices (such as endoscopes) in first world tertiary care hospitals,Eniware's room-temperature,power-independent adaptation of Noxilizer's NO2 sterilization has the potential to prove an unprecedented boon to community health workers,military first responders and disaster relief professionals,enabling fast,safe and cost-effective sterilization of medical instruments any time, anywhere.
Décrivez le but de votre initiative, en insistant sur les résultats que vous souhaitez obtenir
We are trying to improve health equity worldwide by improving access to basic surgery through infection protection and low-cost, power independent sterilization of medical equipment. We are particularly committed to reducing maternal and child morbidity and mortality, to reducing the spread of infectious blood-borne diseases including HIV/AID and hepatitis, and protecting the lives, well-being and productivity of injured people everywhere.
Jusqu'à ce jour, quels résultats a obtenu votre projet ?
Dr. Bernstein began building the Eniware team in November 2011. Currently we are working with Dr. Linda Wright of NIH's Global Network for Women's and Children's Health Research toward clinical field trials of prototype models (one portable plastic bag, one tabletop hard case)in the NICHD settings in India, Kenya, Pakistan and Zambia. We will be partnering with university-based teams to develop the prototypes and with Noxilizer to lab test them for safety and effectiveness. Our integrated development model is designed to develop client streams and distribution/training partners as we develop and field test our prototype models. We are working with Dr. Dan Carucci and other experienced global health professionals to identify and build these partners. Right now we are at the "idea, about to launch" stage. Check back with us in a year and two years for evidence-based data on our impacts!
Quelles sont vos prévisions en termes d'impact au cours des cinq prochaines années ?
Marketing and distribution will be achieved through a phased strategy. Initial penetration will be through key partnerships with established humanitarian and global health programs such as Doctors Without Borders/Médecins Sans Frontières(MSF),the International Committee of the Red Cross(ICRC),UNICEF,Mercy Corps,Partners in Health(Harvard),the Dartmouth Global Health Initiative(GHI) and Gates Foundation HIV prevention grantees. Project partners acquire products for their own use and for local distribution, and train humanitarian responders and local healthcare providers in product use/maintenance. Here are 3 statistics we hope to positively impact: 350,000 maternal deaths from pregnancy complications, 2M women living with fistula, and neonatal infections 20x the rate of the developed world.
Les meilleures propositions possèdent un programme solide détaillant leurs prévisions pour atteindre et suivre leurs objectifs de croissance. Identifiez vos objectifs à 6 mois pour accroître vos résultats
Définissez les trois tâches principales à accomplir pour atteindre ces objectifs à six mois
Tâche 1:
Establish academic partner(s) for prototype design
Tâche 2:
Test and verify prototypes in partnership with Noxilizer
Tâche 3:
Identify and build partnerships for distribution and training
Et maintenant, voyez les choses en plus grand ! Identifiez vos objectifs à 12 mois
Définissez les trois tâches principales à accomplir pour atteindre vos objectifs à 12 mois
Tâche 1:
Clinical field trials of device(s) in partnership with NIH and CDC
Tâche 2:
Finalize partner agreements to use and distribute device(s)
Tâche 3:
Develop and coordinate field training protocols and supports
Viabilité
Quels sont vos différents partenariats ?
We are currently partnered with Noxilizer and NICHD. In the coming months we will hope to formally partner with an academic institution and the CDC for prototype development and a clinical trial. Next we will build out our partnerships to global health organizations, global health funders and disaster response/humanitarian relief organizations. Finally, we will partner with government/inter-governmental agencies including USAID, UNICEF and Ministries of Health.
Actuellement, votre projet cible-t-il d'autres populations, lieux ou marchés spécifiques ? Si oui, lesquels et pourquoi ?
Our license is for health care settings in the developing world including Africa, Asia (except Japan)and the Middle East, and for military and disaster/humanitarian relief worldwide. Our first locations will be those for the clinical trials at Global Network sites in India, Kenya, Pakistan and Zambia. These sites have a particular commitment to data-driven, evidence-based practice. Plus they are incredibly open to working with us.
Quel environnement et quels facteurs organisationnels internes font la réussite de votre projet ?
We operate a lean and mean, high function fast-track team in our virtual office and on site in Washington, DC. We are highly collaborative with just enough ego to think we can pull this off, but not so much that we get in our own way. We are entrepreneurial in temperament with diverse and complementary skill sets. We are all committed to a shared vision of health equity and "doing good, better."
Expliquez plus en détails les besoins et les offres indiqués ci-dessus ou proposez un type d'aide non mentionné dans la liste
 | 11 weeks agoMyra Donnelley said: Great things are happening as we move forward with our project. We have connected with another wonderful company that has created a ... about this Competition Entry. - lire plus > |
| 14 weeks agoMyra Donnelley said: Ruchi.dass - Your kind words are much appreciated. Eniware has licensed a proven, patented NO2 gas sterilant technology from ... about this Competition Entry. - lire plus > |
| 14 weeks agoMyra Donnelley said: Dear Akila - Believe me, this is an easy slip to make. I did it once and nearly gave the team a collective heart attack. NO2 gas has ... about this Competition Entry. - lire plus > |
| 14 weeks agoAkila Maheshwari said: This idea is appealing as it is independent of power- electricity, and of water. I wanted to know about clinical trials done in the USA ... about this Competition Entry. - lire plus > |
| 14 weeks agoRuchi Dass said: A link to your Vimeo video would have helped the commentators and judges.:) However, this is great stuff. Lawrence did mentioned that he ... about this Competition Entry. - lire plus > |
| 15 weeks agoMyra Donnelley updated this Competition Entry. |
| 15 weeks agoMyra Donnelley updated this Competition Entry. |
| 16 weeks agoMyra Donnelley updated this Competition Entry. |
| 22 weeks agoMyra Donnelley updated this Competition Entry. |
| 22 weeks agoMyra Donnelley submitted this idea. |